BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21824611)

  • 1. Efficacy and safety of EMR to completely remove Barrett's esophagus: experience in 41 patients.
    Gerke H; Siddiqui J; Nasr I; Van Handel DM; Jensen CS
    Gastrointest Endosc; 2011 Oct; 74(4):761-71. PubMed ID: 21824611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video).
    Soehendra N; Seewald S; Groth S; Omar S; Seitz U; Zhong Y; de Weerth A; Thonke F; Schroeder S
    Gastrointest Endosc; 2006 May; 63(6):847-52. PubMed ID: 16650552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.
    Giovannini M; Bories E; Pesenti C; Moutardier V; Monges G; Danisi C; Lelong B; Delpero JR
    Endoscopy; 2004 Sep; 36(9):782-7. PubMed ID: 15326573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
    Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
    Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
    Ganz RA; Overholt BF; Sharma VK; Fleischer DE; Shaheen NJ; Lightdale CJ; Freeman SR; Pruitt RE; Urayama SM; Gress F; Pavey DA; Branch MS; Savides TJ; Chang KJ; Muthusamy VR; Bohorfoush AG; Pace SC; DeMeester SR; Eysselein VE; Panjehpour M; Triadafilopoulos G;
    Gastrointest Endosc; 2008 Jul; 68(1):35-40. PubMed ID: 18355819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia.
    Chevaux JB; Piessevaux H; Jouret-Mourin A; Yeung R; Danse E; Deprez PH
    Endoscopy; 2015 Feb; 47(2):103-12. PubMed ID: 25412090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
    Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
    Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma.
    Seewald S; Akaraviputh T; Seitz U; Brand B; Groth S; Mendoza G; He X; Thonke F; Stolte M; Schroeder S; Soehendra N
    Gastrointest Endosc; 2003 Jun; 57(7):854-9. PubMed ID: 12776032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endoscopic mucosal resection of premalignant lesions of the upper gastrointestinal tract].
    Wehrmann T; Lange P; Nakamura M; Riphaus A; Stergiou N
    Z Gastroenterol; 2001 Nov; 39(11):919-28. PubMed ID: 11778151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR.
    Nieponice A; McGrath K; Qureshi I; Beckman EJ; Luketich JD; Gilbert TW; Badylak SF
    Gastrointest Endosc; 2009 Feb; 69(2):289-96. PubMed ID: 18657808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
    Prasad GA; Wang KK; Buttar NS; Wongkeesong LM; Lutzke LS; Borkenhagen LS
    Gastrointest Endosc; 2007 Jan; 65(1):60-6. PubMed ID: 17185080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia].
    Catrambone G; Leoncini G; Iurilli L; Queirolo A; Spinelli A; Taviani M; Mazzarino S
    Minerva Chir; 1999 Oct; 54(10):657-67. PubMed ID: 10575887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotherapy for superficial adenocarcinoma of the esophagus: an American experience.
    Saligram S; Chennat J; Hu H; Davison JM; Fasanella KE; McGrath K
    Gastrointest Endosc; 2013 Jun; 77(6):872-6. PubMed ID: 23472998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
    van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
    Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus.
    Lewis JJ; Rubenstein JH; Singal AG; Elmunzer BJ; Kwon RS; Piraka CR
    Gastrointest Endosc; 2011 Oct; 74(4):753-60. PubMed ID: 21820109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.